As you can imagine, this database exists because it is built on nearly two decades of granular tracking, industry interviews, proprietary datasets (to which AI does not have access), and daily monitoring of the regenerative medicine landscape.
We crowd-source feedback from BioInformant's partners, clients, and readership who contribute new additions and submit company profiles. We are also frequently notified when companies emerge from "stealth mode."
The end result is the world’s only searchable, sortable database of regenerative medicine (RM) companies that is publicly available.
Imagine being able to instantly know the identity of every known regenerative medicine (RM) company worldwide, from small start-ups to industry stalwarts.
You can use it to identify potential clients, partners and collaborators, in-licensing and out-licensing opportunities, M&A targets, market competitors, and so much more.
For 48 hours only, you can claim this global database for an unusual 50% off:
Be Great,
The BioInformant Team
p.s. Remember to act fast, because this offer expires soon!
p.p.s. Interested in other areas, such as iPSCs, MSCs, exosomes, CAR-T cell therapy, and beyond? Explore the
BioInformant Shop.
